FFAs treatment increased AdipoR2 levels, and such increase was strengthened by ATL III treatment, which suggested that AdioR2 maybe not involved in FFAs-induced steatosis of HepG2 cells. This evidence concerns the gene ADIPOR2 and steatosis.